[Treatment of degenerative and inflammatory joint diseases with or without a new synthetic substance (parsalmide). Controlled clinical trial].
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006562:Herpes Zoster / Q000188:drug therapy; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009437:Neuralgia / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007213:Indomethacin
Il trattamento di sindromi morbose degenerative e inflammatorie articolari o non con una nuova sostanza di sintesi (parsalmide). Sperimentazione clinica controllata.